PRO-C6 as a Patient Enrichment Tool for HFpEF Clinical Trials

Time: 2:30 pm
day: Day One


  • Explore biomarkers to identify different endotypes of HFpEF patients are highly needed for precision medicine
  • Discuss how collagen type VI and its signaling – molecule endotrophin have received attention in several pathological processes
  • Analyze PRO-C6, a biomarker of collagen type VI formation and endotrophin, is a powerful prognostic biomarker in HFpEF
  • Learn how PRO-C6 has received a letter of support from the FDA as enrichment tool in HFpEF